CTR FOR ORTHOPEDIC & MULTI - SPEC — History
CCN 370212 | 3-year financial timeline | COVID resilience: 62/100
🛡️ Public data only — no PHI permitted on this instance.
$67M
Latest Revenue (FY2022)
+10.1%
Revenue CAGR (3yr)
27.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $56M | $61M | $67M | +10.6% | +10.1% |
| Operating Expenses | $40M | $43M | $49M | +13.4% | +10.8% |
| Operating Margin | 28.8% | 29.6% | 27.8% | -5.9% | -1.7% |
| Net Income | $16M | $18M | $19M | +4.1% | +8.2% |
| Licensed Beds | 9 | 9 | 9 | +0.0% | +0.0% |
| Total Patient Days | 1,139 | 763 | 630 | -17.4% | -25.6% |
| Medicare Day % | 36% | 35% | 43% | +24.3% | +9.9% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 62/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +21.1% ($56M → $67M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+10.1%
This Hospital
+7.6%
State Avg
Latest Margin
27.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $73M | 27.3% |
| FY2024 (proj) | $79M | 26.8% |
| FY2025 (proj) | $85M | 26.4% |